SUMMARY Upper gastrointestinal function in response to a mixed nutrient meal was evaluated in hyperthyroid patients, both before and after therapy, and in healthy controls. Gastric secretion, gastric emptying, and pancreatic secretion were all normal and normally integrated postprandially in the hyperthyroid patients. Bile acid output was reduced (p < 0.05) in this group of patients relative to healthy controls. Duodenal bile acid concentrations, however, were above the critical micellar concentration in most of the hyperthyroid patients, and the bile acid output and concentration remained unchanged in all patients three months after treatment. After radioactive iodine therapy, when gastrointestinal symptoms were returning toward normal, a small but statistically significant increase in gastric secretion was observed. However, gastric emptying and pancreatic secretion, like biliary secretion, remained unchanged. Abnormalities responsible for the diarrhoea and steatorrhoea in hyperthyroidism appear to reside primarily distal to the duodenum. However, reduced bile acid output may be a contributory factor in some patients.
Although hyperthyroidism is commonly accompanied by gastrointestinal symptoms, which may be severe or even the sole presenting manifestation, their pathophysiology is incompletely understood.1 2 Among the most obvious manifestations are diarrhoea and malabsorption, which have been attributed to hypermotility.34 However, studies of gastric emptying and intestinal transit in hyperthyroid man have been almost exclusively limited to the radiographic observation of transit of an inert barium suspension. Also, although most of these studies have demonstrated increased rate of gastric emptying and shortened bowel transit times, both of which return toward normal after treatment,5 6 some even demonstrate slowed gastric emptying.7 There is only one recent study8 which evaluated gastric emptying of a more physiological meal, whose nutrients can be expected to Healthy controls + SD 6 -Hyperthyroid before therapy therapy, however, the acid output of the patients o---oHyperthyroid, after therapy increased (P<0-05) (Fig. 1) . This was true for the patients who were mildly hypothyroid as well as for those who were euthyroid at the time of repeat 5 -study. In spite of differences in acid output, there were no significant differences in gastric pH between any of the three groups (P>0 05) (Fig. 2) .
Concentrations of fasting serum gastrin were normal in the hyperthyroid patients studied while hypermetabolic (77 +25 pg/ml, mean +SE) and repeated after therapy (69+11 pg/ml). Also, the o 3 -three hour postprandial integrated gastrin responses were similar before (9 6+3 0 ng-min/ml) and after 20\ therapy (8 2+1 7 ng-min/ml) (P>0 05).
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Nutrient delivery from the stomach to the duodenum was normal in the hyperthyroid patients (Fig. 3) 1 _ and did not change after radioactive iodine therapy ( Fig. 3) Bile acid output was less in the hyperthyroid patients than normal controls (P-<0-05) (Fig. 6 ). This output was unchanged after radioactive iodine therapy (P>0-05). Despite the low bile acid output, luminal bile acid concentrations remained above the critical micellar concentration (2 mmol/l) in all except one hyperthyroid patient. Mean bile acid concentrations during the postprandial period in the hyperthyroid patients (before therapy: 3 7± 09mmol/l; after therapy: 38±077mmol/l) were approximately half that found in health (6 6± 0 6 mmol/l). The patient with the very low bile acid concentration and output was patient number 2 in the Table, 
intestinal symptoms. Although bile acid output was decreased in this group, concentrations were above the critical micellar concentration in all except one patient and they could not be correlated with clinical abnormalities. These findings do not support the hypothesis that abnormalities in upper gut function are responsible for the gastrointestinal symptoms in hyperthyroidism.
The previous studies which reported rapid gastric emptying in hyperthyroidism used metabolically inert meals barium suspensions that were followed radiographically.5 6 Such an experimental design evaluates gastric emptying independent of the nutrient-stimulated intrinsic regulators of gastric function. The present study quantifies the delivery to the duodenum of gastric contents (gastric secretions plus meal) as well as meal nutrientsboth are normal after this mixed nutrient meal in hyperthyroidism, confirming and extending the observation of Wiley et al.8 who found normal meal marker emptying after a nutrient meal. One patient in our series had eight to 10 stools with 21 g faecal fat per 24 hours while hyperthyroid and only one stool daily after radioactive iodine therapy, yet nutrient delivery to the bowel was identical during the initial and repeat studies. There were differences in postprandial gastric secretion and intragastric volume, however, between the studies performed while the patients were hyperthyroid and those performed after radioactive iodine therapy when the patients were euthyroid or hypothyroid. After therapy, patients secrete more acid and maintain greater intragastric volumes, but this trend away from normal values was associated with normalisation of digestive symptoms. In fact, our patients continued to maintain normal nutrient and volume delivery to the bowel, even though gastric secretion increased. It is not clear why these differences occur. Basal gastrin concentrations and postprandial integrated gastrin responses were similar before and after treatment. Patients who were euthyroid at the repeat study responded similarly to those who were hypothyroid. Perhaps the differences in gastric secretion and emptying were an effect of the radioactive iodine, known to be concentrated in the gastric mucosa as well as in the thyroid.2 Also, the time course of these changes after therapy is unknown.
This characterisation of upper gastrointestinal function in response to a mixed nutrient meal in hyperthyroidism suggests that the site of abnormalities responsible for gastrointestinal symptoms in these patients resides distal to the duodenum. It will be important to evaluate postprandial small bowel and colon function in hyperthyroid man. 
